Project Details
Description
Development of Oncolytic Adenovirus with Novel Targeting Capability for CRPC
Status | Finished |
---|---|
Effective start/end date | 2/1/17 → 3/29/19 |
Funding
- ASTELLAS PHARMA, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.